Analyst Research

Report Title Price
Provider: Stock Traders Daily
Provider: Griffin Securities, Inc.
Provider: Thomson Reuters Stock Report
Provider: ValuEngine, Inc.

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Intrexon Corp completes acquisition of Medistem Inc

Friday, 7 Mar 2014 08:30am EST 

Intrexon Corp:Completes acquisition of San Diego-based Medistem, Inc.Upon integration of these platforms, ERCs could be manufactured as genetically modified vehicles to secrete therapeutic effectors in body for clinical benefit to patients suffering from many different diseases.Medistem stockholders will receive in exchange for each share of Medistem common stock $0.27 in cash and $1.08 worth of Intrexon common stock, or about 0.03920 shares.Says receives based on t20-day volume-weighted average price of Intrexon's common stock immediately prior to closing. 

Company Quote

0.67 +2.63%
24 Dec 2014